Abstract: BACKGROUND: Meso-tetra-hydroxyphenyl-chlorine (mTHPC) is among the most powerful photosensitizers available for photodynamic therapy (PDT). However, the mechanisms leading to cell death are poorly understood. We here focused on changes at DNA and RNA levels after treatment with the liposomal mTHPC derivative Foslipos in vitro. METHODS: After determination of darktoxicity, laser conditions and uptake kinetics, PC-3 prostate carcinoma cells were subjected to PDT with Foslipos, followed by assessment of cell numbers directly (TP0) or 1h (TP1), 2h (TP2), 5h (TP5) and 24h (TP24) after illumination. Nucleic acids had been extracted for evaluation of RNA amounts and integrity as well as for estimation of abasic sites as a measure for DNA damage. Furthermore, expression changes of 84 genes related to oxidative stress were investigated by quantitative polymerase chain reaction. RESULTS: Already at TP0, the number of dead cells was significantly higher after PDT versus controls and at TP24 more than 90% of cells had been destroyed. PDT resulted in a severe damage of both RNA and DNA. Gene expression analyses revealed an impact of PDT on pathways for oxidative and metabolic stress, heat shock, proliferation and carcinogenesis, growth arrest, inflammation, DNA repair and apoptosis signaling. CONCLUSIONS: Mechanisms of Foslipos-mediated PDT comprise a combination of acute and delayed lethal effects in PC-3 cells. The latter may include death processes initiated by nucleic acid damage, activation of stress and growth arrest genes in combination with a reduced capability to adequately cope with oxidative toxicity. Our results will help to better understand molecular photodynamic effects. 
Introduction
Currently, one of the most powerful second-generation photosensitizers available for photodynamic therapy (PDT) is meso-tetra-hydroxyphenyl-chlorine (mTHPC, Temoporfin), a member of the chlorin family of photosensitizers. The commercial product Foscan gained approval in the EC for palliative PDT treatment of patients with recurrent or refractory head and neck cancers, but it is also under investigation as a promising therapeutic modality for early cancers of the head and neck region, colon adenocarcinoma, non-melanotic skin tumors, pleural mesothelioma, pancreas cancer, hepatoma, carcinoma in-situ of the vulva, malignant brain tumors, ovarian neoplasms, and organ confined prostate cancer [1, 2] .
However, Foscan is highly hydrophobic and thus requires the use of organic solvents like alcohols, acetone or ethyl acetate. After intravenous injection in patients, mTHPC molecules tend to aggregate and display very complex biokinetics, such as e.g. a series of subsequent concentration maxima in plasma or limitations in transportation and tumoruptake [3, 4] . In recent years, these clinically unfavorable characteristics prompted the development of new derivatives of Temoporfin, including the liposomal formulations Foslip and Fospeg (the latter being PEGylated). In addition to the advantage of solvency in hydrophilic media, in first in-vivo and in-vitro studies liposome-incorporated mTHPC had been shown to accumulate faster, selectively and with higher fluorescence in tumor tissues [5] [6] [7] [8] .
The cell death pathways evoked by oxidative damage in mTHPC-mediated PDT are far from being clear and appear to depend not only on cell type investigated but also on PDT protocol. It had been reported that apoptotic pathways may be initiated [9] [10] [11] [12] , however, autophagy or necrosis [13] may prevail -especially if high PDT doses are applied [14] .
To date only a limited number of studies are available that focus on the spectrum of signaling pathways affected in the course of mTHPC-mediated PDT. Apparently, effects may not only include activation of caspase cascades [10, 11] but also acute-phase response processes [15] , and expression changes of heat-shock proteins [16] , hypoxiamarkers [17] , matrix metalloproteinases [18] or cytokines [19] . Since some of these cellular responses may modify, delay or even counteract cell death mechanisms, detailed analyses are highly needed.
With the aim to elucidate pathways leading to and/or interfering with cell death in PDT procedures with liposomal mTHPC we here focus on changes at the DNA and RNA level, as well as on gene expression profiles, using the established prostate carcinoma cell line PC-3 as model system.
Material and Methods

Cell line and reagents
The androgen-independent human prostate carcinoma cell line PC-3 was obtained from the European Collection of Cell Cultures (ECACC). Cells were grown in DMEM+ (1:1 mixture of DMEM and Ham's F-12, without phenol red indicator and pyridoxal HCl, supplemented with 10% fetal calf serum and 1% Penicillin-Streptomycin, 10.000 UI/ml, all purchased from Gibco, Basel, Switzerland) at 37°C and 5% CO 2 in a humid environment. Cells were passaged by trypsinization using 1x trypsin/EDTA (Invitrogen, Basel, Switzerland). As photosensitizer, we used mTHPC encapsulated into dipalmitoylphosphatidylcholine/dipalmitoylphosphatidylglycerol (DPPC/DPPG) liposomes (Foslipos, Biolitec AG, Jena, Germany). Unless otherwise stated, chemicals were purchased from Sigma, Buchs, Switzerland.
Dark toxicity assay
PC-3 cells were plated at a density of 1000 cells per 60 mm Petri dish and allowed to attach for 24 h. Thereafter, Foslipos was added to end concentrations of 0.1, 0.5, 1.0, 5.0, and 10.0 μg/ml, respectively, and incubated for 5h. Then a colony forming assay was performed as described earlier [20] . Briefly, after treatment, cells were washed with PBS and fresh DMEM+ was added. Cells were cultured for another 10 days and colonies were fixed, stained with azur-methylenblue-Giemsa and counted, whereby only colonies containing ≥50 cells were considered. Controls were run under the same conditions, while Foslipos was omitted.
Selection of laser intensity
PC-3 cells were processed as for the dark toxicity assay described above with the exception that cells were exposed to laser light after the 5 h incubation period with
Foslipos. Laser intensities of 1, 3, and 5 J/cm 2 , respectively, were applied, using a diode laser (Applied Optronics Corporation, USA) at 652 nm and a powermeter (Lightwave OMM6810B, GMP, Renens, Switzerland). After irradiation, colony forming assays were carried out as described above.
Confocal laser scanning microscopy
PC-3 cells grown on cover slips were incubated with 5 μg/ml Foslipos for 15 min, and 1, 2, 3, 4, and 5 hours, respectively. After a buffer wash, cells were fixed with 4% buffered paraformaldehyde, again washed, coverslipped with Glycergel (Dako, Baar, Switzerland) and analyzed with a confocal laser scanning microscope (SP2, Leica Microsystems, Heerbrugg, Switzerland), using an excitation wavelength of 488nm and detection wavelengths of 580-660nm.
Cell culture treatment
PC-3 cells were plated at a density of 1x10 6 , allowed to recover for 24 h and treated with After washing all samples with PBS, fresh DMEM+ medium was added and the dishes were placed back in the incubator. Experiments were stopped immediately (i.e. after about 3-4 min) or after 1, 2, 5, and 24 h, respectively, by 2 x 3 min washing and 5 min trypsinization. These five time points are refered to as TP0, TP1, TP2, TP5 and TP24.
After centrifugation at 1000 rpm for 5 min, cell pellets were resuspended in 1 ml PBS and either directly used for cell counting or frozen for later nucleic acid analyses.
Cell survival test
Resuspended cells (10 μl) from experimental settings described in "cell culture treatment" were mixed with equal volumes of trypan blue solution (0.5%, Serva, Buchs, Switzerland) and cells (dead and alive) were immediately counted in a Neubauer chamber.
Nucleic acid extractions and quality analyses
From the remainder of resuspended cells (i.e. 990 μl), genomic DNA and total RNA was extracted with the NucleoSpin RNA II kit in conjunction with the NucleoSpin RNA/DNA buffer set (Macherey-Nagel, Oensingen, Switzerland), following the protocol of the manufacturer. The kit allows for a sequential elution of DNA and RNA from the same cell lysate using a silica membrane filter column and a set of predesigned buffers. Final elution volumes per sample for genomic DNA and total RNA were 100 μl and 60 μl, respectively. Nucleic acid concentrations were determined with a Nanodrop spectrophotometer (ND-1000, Wilmington, DE). The number of abasic sites within the genomic DNA was determined by comparison with the standard curve.
Gene expression analyses
For gene expression analyses, the PAHS-003 RT 2 Profiler PCR array system was performed according to instructions of the manufacturer (Human stress and toxicity pathways finder array, SuperArray, Frederick, MD). Briefly, 0.5 µg total RNA each from samples TP1 (PDT and CO) and TP5 (PDT and CO) were reverse transcribed with the RT 2 First Strand kit (SuperArray). Resulting cDNA was subjected to quantitative PCR (qPCR) on an ABI 7500 sequence detection system (Applied Biosystems, Rotkreuz, Switzerland) using the supplied 96-well plate format with pre-dispensed specific primer sets and the RT 2 SYBR green/ROX qPCR master mix (SuperArray). Cycling parameters were as follows: 1 cycle for 10min at 95°C and 40 cycles of 15sec at 95°C and 1min at 60°C. Both threshold and baseline values were automatically obtained by the SDS software (Applied Biosystems) and CTs for all wells were exported to the company's data analysis web tool (www. superarray.com).
Statistical analyses
All experiments were carried out in triplicate. Statistical analyses were performed with the StatView software (www.statview.com). All possible pairwise differences between time points as well as between experimental conditions were examined by Fisher's Protected Least Significant Difference (PLSD) tests. P-values less than 0.05 were considered significant.
Results
Experimental conditions
With the aim to establish the appropriate experimental conditions, we first determined the maximal non dark-toxic concentration of Foslipos. We found that colony numbers after treatment with 10 μg/ml Foslipos were significantly lower compared to untreated controls (p<0.0001), while all other concentrations of Foslipos used showed no statistically significant effects compared to controls ( fig. 1 ). We thus decided to perform further experiments with 5 µg/ml Foslipos end concentration in the medium. We next investigated the conditions of light exposure with minimal lethal effect at 5 μg/ml Foslipos. 1 J/cm 2 showed the lowest phototoxic effect (data not shown) and was thus choosen for our further study.
Microscopy
Cellular uptake kinetics of Foslipos in PC-3 cells were evaluated on the basis of its intracellular fluorescence ( fig. 2 ). Already after 15 min, a weak signal was detectable within cells. The fluorescence intensity increased steadily over time, reaching a maximum at 4h. It was always diffusely distributed throughout the cytoplasm, with a tendency for a higher signal accumulation in the vicinity of the nucleus. However, the nuclear compartement itself always remained non-fluorescent ( fig. 2 ).
PDT-effects on cell death
As shown in fig. 3 , up from the earliest time point investigated (TP0), PDT samples contained statistically significant more dead cells than untreated controls (p=0.0002), 
Effects on nucleic acid quantitiy and integrity
Genomic DNA damage was estimated by measuring the amount of apurinic/apyrimidinic sites -a marker for oxidative stress ( fig. 4) . We found that at all time points measured (TP0, TP1, TP24), the degree of oxidative DNA damage was significantly higher in PDTtreated cells compared to CO samples (TP0, p<0.0001; TP1, p<0.0001; TP24, p<0.0001).
DNA quality was also impaired in FOS and IRR samples (compared to CO), however, the difference between PDT and FOS or IRR was still statistically significant at all time points measured (in all cases: p<0.0001). Generally, DNA damage of PDT-treated cells 
Effects on gene expression profiles
With the aim to further characterize the effects of Foslipos-mediated PDT, we investigated the expression of 84 genes involved in stress and toxicity pathways by qPCR at TP1 and TP5. Taken together, we found that roughly 57% of all genes investigated changed at least two-fold in expression after PDT. Of these, the majority showed reduced transcript numbers at TP1 (about 83%). Over time, most of the regulated genes (about 54%) maintained their initially changed expression levels. However, at TP5 vs. TP1, about 23% had been further downregulated (HSPA4, CCNC, CCND1, E2F1, NFKB1, ATM, DDB1, BCL2L1, CASP8, CASP10, FASLG), about 12% displayed an further upregulation (CRYAB, DNAJB4, HSPA1A, HSPA1L, HSPA6), and about 10% showed signs of recovery (GSTM3, HSPA2, ERCC3, RAD50, TNFRSF1A, TNFSF10). Tables   1-7 summarize those genes whose expression changed more than twofold between CO vs. PDT and/or over time.
In addition, we found that the following genes are expressed in PC-3 but do not appear to 
Discussion
Several new strategies are currently under development aiming to improve the efficiency and specificity of PDT. In this context, liposomal photosensitizer preparations are of interest mainly for two reasons: on the one hand they may serve as useful carriers for hydrophobic photoactive molecules in biosystems and on the other hand, they may possess a high payload for targeting molecules. Among others, the photosensitizer mTHPC had been incorporated into different types of liposomes and successfully applied in PDT protocols in-vitro and in-vivo [5, 6, 8, [21] [22] [23] [24] . However, the lack of information on molecular effects prompted us to explore cellular mechanisms in PDT with the DDPG/DDPC liposomal mTHPC derivative Foslipos, using the prostate carcinoma cell line PC-3 as model.
Our microscopic studies on the cellular uptake showed that Foslipos is quickly accumulating in the cytoplasm of PC-3 cells while always sparing the nucleus. We conclude that liposomal preparations do not affect the intracellular distribution since comparable patterns had been reported for mTHPC in a variety of human cell lines [25] [26] [27] .
As shown before for PC-3-grafted mice [28] , PC-3 cells are highly responsive for mTHPC-mediated PDT. Under our experimental conditions we repetitively observed an over 90% reduced cell count 24h after PDT with Foslipos compared to untreated controls.
However, the kinetics of this reaction were not linear but rather characterized by a twostep process with an initial death of cells, being already significant a few minutes after light application in PDT (i.e. at TP0) and a second -stronger -boost occuring more than 5h later. Likely, the first "hit" is due to direct detrimental actions of short-lived reactive oxygen species (ROS), that are known to be generated in fractions of seconds after PDT and apparently kill a portion of cells immediately. However, the majority of cells seemed to be merely damaged by ROS and eventually undergo a death process that takes several hours. Whether the latter is related to apoptosis was not within the scope of our experiments and will be the focus of further studies.
To investigate the mechanisms leading to the observed photodynamic effects in more detail we performed experiments to characterize damaging effects on nucleic acids.
Results for DNA damage, RNA amount and integrity supports our above observation of an acute PDT effect, that can be documented already shortly after light application.
Since we were unable to localize photosensitizer fluorescence to the cell nucleus, it was surprising that directly after PDT a significant number of DNA strand breaks due to base loss were already detectable. However, results may be explained by mechanisms similar to those observed in a murine glioma cell line, where mTHPC entered the nucleus during light application [29] . The profound and early DNA damage may account for instant cell destruction but -if not repaired -may also result in e.g. blocked DNA replication eventually leading to initiation of death cascades. Notably, even within 24h after PDT no recovery of the number of abasic sites (compared to TP1) was detected, indicating that no DNA repair had been initiated. At the RNA level these results are complemented by the observation that several important genes associated with DNA repair mechanisms had been transcriptionally downregulated or destroyed after PDT with Foslipos. These include the early DNA damage sensor ATM, DDB1, that is a subunit of the damagespecific DNA binding protein complex, the DNA excision repair endonucleases ERCC1
and ERCC3, the postreplication DNA repair genes RAD23A and RAD50, the uracil-DNA glycosylase UNG and the DNA double strand repair proteins XRCC1 and XRCC2.
Furthermore, RNA for PCNA, that is involved in base-excision repair pathways, was reduced. However, low DNA repair capacities have dual effects: they confer a cytotoxicity favorable for PDT by triggering cell death but surviving cells are prone to mutations with unpredictable consequences. In worst case this may result in secondary malignancies after PDT. Our data are in accordance with those in murine gliobastoma cells where mTHPC-PDT also resulted in an immediate DNA damage, however, in this study and others activation of repair mechanisms after PDT had been reported [29] [30] [31] [32] .
Since our data are in contrast to in-vitro studies in human myeloid leukaemia and nasopharyngeal carcinoma cells where no DNA damage was found after mTHPC-PDT [33, 34] , the observed effect may depend on cell line.
The significantly lower readings at TP0 of RNA content per cell after PDT vs. all controls indicate that some RNA was initially destroyed, -presumably by an acute and direct effect of ROS on RNA and not by transcriptional regulation. Not unexpected, the major part of specific genes investigated here thus displayed lower transcript numbers after PDT. Since total RNA consists to 90-95% of ribosomal RNA (rRNA), our data may also point towards an impact of PDT on the translational machinery itself. Interestingly, illumination alone (IRR) lead to a significant increase of RNA amounts measured at TP24, so that actually an interaction of effects elicited by light on the one hand and ROS on the other hand may take place after PDT.
Our further RNA expression studies focusing on established genes involved in stress and toxicity indicated a very complex molecular response of PC-3 cells to mTHPC-mediated PDT, including both higher or lower transcript levels of genes with the potential to either support or counter-act PDT actions. While a higher gene expression is due to an upregulation, lower expression scores may be either a sign of PDT-related RNA destruction or of true downregulation. The latter may well be a consequence of the observed oxidative DNA damage after PDT. However, with regard to possible damage of rRNA in PDT it is far from clear whether upregulated transcripts are in fact translated into proteins.
Our study reveals reduced levels of genes involved in cellular defense mechanisms against oxidative and metabolic stress. PDT with other photosensitizers are partly in accordance [35, 36] and partly in contrast to our data [37, 38] . Because CAT and SOD1
have been shown to protect cells against phototoxic effects of hematophorphyrin derivative or ALA in vitro [39, 40] and inhibition of SODs results in increased PDT effects [41] , we hypothesize that the reduced ability of the cells to cope with oxidative and metabolic stress may constitute an important mechanism for PDT effects with
Foslipos. However, as in other studies [42, 43] , we found that two antioxidant defense genes (CRYAB and HMOX1) were strongly upregulated. The small heat shock protein CRYAB and the heme oxygenase family member HMOX are known to act as antiapoptotic molecules that protect cells against oxidative damage [44] . Together with the observation that inhibition of HMOX may increase the efficacy of PDT [43, 45] , we
propose that -if translated -high levels of HMOX or CRYAB may eventually prevent optimal phototoxic effects.
Expression patterns of heat-shock proteins (HSPs) in our study turned out to be very complex. Several previous papers reported the induction of HSP60, HSP70 or HSP90
after PDT with various photosensitizers [46] [47] [48] [49] [50] [51] . However, HSPs consist of large protein families and in our study we found that expression of members may be downregulated or upregulated after PDT with Foslipos. Upregulation of the HSP40 member DNAJB4 as well as HSP70 members HSPA1A, HSPA1L and especially HSPA6, that is only induced by severe stress-stimuli, may mirror the extent of damage in our model but also indicate the presence of a (partly) preserved stress-response system. On the other hand it should be noted that RNA levels of several HSP members investigated here are downregulated.
Thus protective mechanisms by HSPs may be rather impaired after PDT with Foslipos.
Notably, some of the downregulated HSP70 members belong to essential house keeping genes.
PDT with Foslipos may not only have direct destructive effects on cells but may also block proliferation and induce cell cycle arrest in survivors. Since cell damage is obviously so profound that repair mechanisms are not operative, death pathways are eventually activated. As reported in part previously [52] [53] [54] , transcripts of cyclin family genes CCNC, CCND1 and CCNG1 as well as of PCNA, a protein crucial for DNA replication, were markedly reduced after PDT in our model thereby possibly leading to a diminished proliferative activity. However, the observed downregulation of cyclininteracting transcription factor E2F1 may also directly promote cell death, as reported previously for PC-3 cells [55] . The tumor suppressor p53 (TP53) is regarded as a key factor for the regulation of cell growth and death. Interestingly, we and others [56] found that PDT did not change the expression of this gene. However, the expression of one of the main targets of TP53, the cyclin-dependent kinase inhibitor CDKN1A, was reduced after PDT in our study, further supporting an impact of PDT on cell cycle processes. Our data are in contrast to PDT studies that report an increase in CDKN1A [57] . Since MDM2, an important inhibiting factor of p53, was reduced in our study, the ratio of MDM2 to TP53 apparently changed. This may be associated with the potential of increased p53-related pathways and/or reduced p53 degradation followed by cell cycle arrest and apoptosis. Furthermore, we found a strong upregulation of the bZIP transcription factor DDIT3 -notably independent of p53 -after PDT. Since DDIT3 had been implicated in anti-proliferative effects and the induction of apoptosis by certain anticancer agents, including in PC-3 cells [58] , the observed high levels may have also contributed to growth arrest and apoptotic signaling in our experiment after PDT.
We here report a marked downregulation of IGFBP6 after PDT. Being a relatively specific inhibitor of IGF-II action, high levels of IGFBP-6 had been found to block proliferation and increase apoptosis in-vitro, including in PC-3 cells [59, 60] .
In our study, genes involved in apoptosis signaling all displayed reduced transcript numbers. Most of these genes seem to be damaged early -probably due to direct ROS effects. TNFRSF1A, that binds CASP8, as well as both the apoptosis-inducing ligands TNFSF10 and FASLG are almost completely shut down already at TP1 in our model. 
